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Introduction Proliferative enteropathy, caused by the obligate intracellular bacterium Lawsonia
intracellularis (McOrist et al., 1995), is a widely distributed disease throughout the world causing
substantial economic loss. The diagnostics of the disease is complicated by limited value of sero-
logical surveys (Lawson et al., 1988; McOrist et al., 1992) as well as the fact that L. intracellularis
can only be cultured in cell cultures (Lawson et al., 1993). Thus the development of methods to
detect the agent in faecal samples is important for both diagnostic and epidemiological purposes.
The development of monoclonal antibodies for diagnostic purposes is labor intensive and time
consuming. This drawback can be eliminated by using recombinant antibodies selected by phage
display technology. This methodology has been used successfully to produce antibodies against a
variety of pathogens. The aim of this study was the selection of recombinant antibodies against
Lawsonia intracellularis.
Materials and Methods Selection of the phage display library. We used a Human Synthetic VH +
VL scFv (Griffin 1) Library from the Laboratory of Molecular Medicine, MRC, Cambridge. The
library is in a phagemid format that allows scFv can be expressed either on the surface of a bac-
terial virus or in an alternative E. coli host as a plasmid producing a soluble scFv. The scFv frag-
ments have a c-myc and a poly-histidine tag to facilitate detection and purification. The diversity of
the library is estimated to be 1.2x109 clones.
The selection was performed on bacterial cells coated as the antigen on the surface of glass
slides. The panning was performed with approximately 3x1012 phages. Unbound phages were
removed by washing and remaining bound phages were eluted by triethylamine. Exponentially
growing TG1 cells were infected by eluted phage particles, spread on 2xYT plates. After helper
phage infection (M13 K07 phage), phage supernatants were precipitated and reused for another
cycle of panning on the same antigen. In total, four rounds of panning were repeated. The enrich-
ment of specific phages in each round of selection was assessed by immunofluorescence.
Results At the end of the selection process, 5 phage clones with Lawsonia intracellularis reactivity
were isolated. When the DNAs coding for these 5 scFv antibodies were analyzed by DNA finger-
printing, two patterns were identified indicating that at least two independent clones were select-
ed. Both clones showed moderate values of kinetic equilibrium association constant and both were
able to bind bacterial cells in histological sections. Selected clones were further characterized by
sequencing and showed moderate values of the kinetic equilibrium association constant.
Conclusions We have selected first recombinant scFv antibodies recognizing one of the surface
proteins of Lawsonia intracellularis which could improve diagnostics of porcine proliferative enteritis.
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Abstract In two longitudinal studies, we examined the transmission dynamics of antimicrobial
resistance (AMR) in an integrated, semi-closed population of humans and swine. A total of 1594
human and 1508 swine Escherichia coli (EC) and Enterococcus faecalis (EF) isolated from human
wastewater and swine fecal samples were tested for antimicrobial susceptibility, for the presence
of Class I integrons and gene cassettes that encode for AMR, and for the prevalence of van-
comycin-resistant Enterococcus faecium (VRE). We showed that swine EC and EF had a higher
prevalence of AMR than human isolates and that both swine and human EC had a low prevalence
of Class I integrons. We isolated a total of 50 VRE from human wastewater samples and no VRE
from swine samples. We concluded there was no apparent transfer of AMR from swine to human
or vice versa, and that VRE may be more prevalent in the environment than previously thought.
Introduction It is generally perceived by the medical community that antimicrobial resistance
(AMR) in human infections is a consequence of sub-therapeutic antibiotic usage in animal produc-
tion (Anderson, 1999). Because no definitive studies have determined this phenomenon, con-
trolled epidemiologic studies with stable human and animal populations are needed to identify the
transmission dynamics of AMR (Khachatourians, 1998). Scott et al., (2005) conducted a cross-sec-
tional study in a uniquely integrated population of humans and swine to begin to address this
need. Preliminary results suggested that occupational exposure of humans to swine did not
appear to be associated with the prevalence of AMR in commensal fecal Escherichia coli (EC).
The current study is a longitudinal continuation of the previous study in the same population
(Scott et al., 2005). The objective of this study was to generate data over a two year period on the
AMR phenotypic and genotypic profiles and potential AMR transmission dynamics of EC,
Enterococcus faecalis (EF), and E. faecium in a semi-closed population of swine and humans.  
Materials and Methods
Study Population The study design has been described (Scott et al., 2005; Campbell et al., 2005;
Poole et al., 2005). The study population was composed of humans and swine in a semi-closed
vertically integrated food system distributed over widely diverse geographical locations. There was
moderate movement of humans into the system, but little movement out of the system. There
was very little movement of swine (purebred breeding stock) into the system and no movement
of swine out of the system. For the first year, the human population sampled was 21,000 and the
swine sampled averaged about 45,000. During the second year, the representative human popu-
lation was 39,000, whereas the swine population numbered 52,000.
Bacteriology In the second year of the study, 987 human wastewater and 931composite swine
fecal samples were cultured for the presence of commensal EC by use of CHROMagar-E. coli
(DRG International, Mountainside, NJ) agar and confirmed as EC by API 20 test kits (API,
bioMerieux, Hazelwood, NJ). Swine and human samples were streaked onto m-Enterococcus
agar (Becton Dickinson, Sparks, MD) for EF isolations. API test kits were employed for species
identification. Swine and human samples were also streaked onto M-Enterococcus agar that con-
tained 20 µg vancomycin to screen for the presence of vancomycin-resistant E. faecium (VRE).
Suspect VRE were verified by use of API test kits and PCR.
Antibiotic Sensitivity Testing Minimum inhibitory concentrations of 16 and 19 antibiotics were
determined by use of a micro-broth test kit (Sensititre™, Trek, Inc., Cleveland, OH) that employed
antibiotic panels from the National Antimicrobial Resistance Monitoring System (NARMS).
Susceptibility testing was performed on 829 human and 857 swine EC, and 345 human and 279
swine EF isolates from the second year sampling.  EC isolates from the first year samples were pre-
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viously characterized for antibiotic sensitivity (Scott, et al., 2005) and were examined genotypically.
PCR Analysis From samples isolated the first year, PCR was run on a total of 729 EC (n=420
human, n=372 swine) to look for the presence of integrons and gene cassettes encoding for
AMR. Briefly, PCR was used to amplify the Class I integrase and subsequently any AMR gene
cassettes which may be inserted between the integron variable regions (5‘ conserved sequence
and the 3’ conserved sequence) as previously described (Levesque et al., 1995). DNA sequencing
of PCR products were submitted to the DNA Core Facility, Department of Veterinary Pathobiology,
Texas A&M University.  The BLAST program at the National Center for Biotechnology Information
(Altschul et al., 1997) was used to identify AMR gene cassettes. 
Pulsed Field Gel Electrophoresis (PFGE) Isolates that grew on vancomycin plates that were ver-
ified as E. faecium by API test kits and PCR were then subjected to PFGE to determine geno-
types. The PCR procedures for identification of E. faecium have been described (Jackson et al.,
2004) as well as techniques for PFGE analysis (Poole, 2001). 
Results A total of 23 human EC isolates from the first year of sampling were positive for the
Class I integrase, whereas 9 of these were positive for AMR gene cassettes. The remaining 14
had insertion of DNA into the integron (range 525-1000 bp); however, none had known resistance
genes from the Genbank database. Seven of 9 samples were positive for aadA gene, 3 of 9 were
positive for dfr, whereas ant-3 was present in one sample. These genes encode for resistance to
spectinomycin and streptomycin, trimethoprim, and spectinomcyin and streptomycin, respective-
ly. Of the swine isolates, 36 were positive for Class I integrase and five of these were positive for
the aadA gene, which confers resistance to spectinomycin and streptomycin. Although the
remaining 31 had DNA inserted into the integron (range 200-990 bp), none matched known resist-
ance genes in the database of Genbank.   
Of the human EC in the second year of sampling, 53% were pan susceptible, 26% were
singly resistant, 21% were resistant to 2 or more, and 8 (0.81%) were resistant to 5 or more
antimicrobials. When the human EF were examined, 3% were pan susceptible, 9% were singly
resistant, 88% were resistant to 2 or more, and 61 (6.2%) were resistant to 5 or more antimicro-
bials. Of the swine EC, 12% were pan susceptible, 37% were singly resistant, 51% were resist-
ant to 2 or more, and 20 (2.1%) were resistant to 5 or more antimicrobials. The swine EF had
none that were pan susceptible, 1% that was singly resistant, 99% resistant to 2 or more, and
159 (17.1%) that were resistant to 5 or more antimicrobials.
During the first two years of these studies, there were 50 VRE isolated from human waste-
water samples from multiple geographic locations. None of the swine fecal samples were posi-
tive for VRE, nor were any of the EF resistant to high levels of vancomycin. Forty-nine of the VRE
carried the vanA glycopeptide resistance gene cluster and one carried the vanB cluster.  There
were 23 separate genotypes, segregated into three groups (I, II, III) as determined by PFGE.
Fourteen of the PFGE types came from sites that had farms, and 7 came from non-farm sources.
All of our isolates had vancomycin resistance at >32 µg/ml, the majority were resistant to gen-
tamicin at >1024 µg/ml, but all were sensitive to quinupristin/dalfopristin at <1.0 µg/ml.  
Discussion The present paper is a preliminary report of two other studies that originated from
this longitudinal study and will be presented elsewhere (Campbell et al., 2005; Poole et al., 2005).
The initial report of the transmission dynamics of EC in swine and human populations for the first
year of sampling has been described (Scott et al., 2005).  
When looking for genetic factors associated with AMR in the present study, we found that
human EC isolates tended to have an integron-encoded AMR gene cassette when compared to
swine isolates, even though swine isolates were more likely to have a Class I integron than iso-
lates from humans. In this study, there was a low prevalence of Class I integrons and AMR gene
cassettes observed in both swine and human isolates, which contrasts with that seen in other
studies. In those studies, the majority of AMR genes in Gram-negative bacteria were located
within the Classs I integron (Winkobur et al., 2001; Leverstein-van Hall et al., 2002).  Similar to our
study, White et al., (2001) observed greater AMR in swine isolates than human isolates, but a
decreased prevalence of Class I integrons. Unlike that study, we found that swine had an
increased prevalence of Class I integrons compared to humans isolates, whereas human isolates
were more likely to have an AMR gene cassette present. In agreement with our study, those
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authors (White et al., 2001) found an 87% prevalence of aadA genes within the Class I integron,
while we observed a prevalence of 78% in human isolates and 100% in swine isolates.  We
hypothesize that the reduced prevalence of Class I integrons in our study could be because our
samples were environmental in nature and not clinically derived. It also possible that the preva-
lence of Class I integrons were underestimated because we used genomic DNA templates from
only those isolates we were able to culture.
In our study, AMR was greater in swine isolates than in human isolates and these results
agree with that observed for the first-year samples (Scott et al., 2005). For example, in the earlier
study, there were 50.4% pan-susceptible human EC isolates compared to 53% in the present
study. In the former study, 15% of human EC were resistant to 3 or more antibiotics compared to
21% that were resistant to 2 or more in the present study. In our study, swine EF were consider-
ably more resistant than human EF, particularly when we compare the resistance of human EF
(6.2%) to swine EF (17.1%) to 5 or more antimicrobials. Our study also agrees with that of White
et al., (2001) in which EC from humans, swine, cattle, and poultry were collected over a 24-year
period and swine EC isolates showed greater resistance than human isolates. In the present
study, we were unable to demonstrate evidence for transfer of resistance from swine to humans
or vice versa and these results mirror those of Scott et al., (2005).
The isolation of VRE (E. faecium) in the present study is believed to be the first environmental,
non-clinically associated isolation in the U.S. This is in contrast to that seen in European VRE. In
those countries, both E. faecalis and E. faecium isolates have been demonstrated as VRE and
have been isolated from wastewater, livestock, foods, and healthy humans (Klare et al., 2003;
Witte, 1998; Witte, 2000). In the U.S., VRE are an important source of nosocomial infections and
have been isolated primarily from hospitals and hospital wastewater (Coque et al., 1996; Harwood
et al., 2001). It is interesting to note in our study that out of a total of 50 isolates, only 10 were
associated with wastewater from 2 in-patient medical facilities. The remaining VRE were from
housing units of swine- and non-swine workers from geographical locations that ranged up to 200
km in distance from each other. Although some VRE genotypes suggested a clonal nature, most
isolates were genotypically distinct. We observed clonal VRE at separate geographic locations,
and distinctly different genotypes at the same location. We are at a loss to explain this dichotomy,
but theorize that on the basis of the large number of VRE isolated, the background level of VRE in
human populations is greater that previously perceived.
Conclusions Our preliminary results suggest that swine EC have a low prevalence of Class I inte-
grons, that human EC are more likely than swine EC to have a gene cassette present, that swine
EC and EF have increased AMR compared to human isolates, that there was no apparent AMR
transfer from swine to humans or vice versa, and that VRE may be more common in the environ-
ment that previously thought. Longitudinal studies in this population will continue until 2007, and we
will further characterize AMR by determining the prevalence of genetic factors that encode for AMR.  
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